Rima Patel, MD
Retina Specialist · Phoenix, AZNPI 1013353804
Payments from drug & device makers
Across 229 payments — averaging $353.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim International GmbH$46K
- ANI Pharmaceuticals, Inc.$16K
- Bausch & Lomb Americas Inc.$5K
- Alimera Sciences, Inc.$4K
- Regeneron Healthcare Solutions, Inc.$2K
- Genentech, Inc.$2K
- plus $6K from 18 others
Across 14 payments — averaging $1953.40 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alimera Sciences, Inc.$27K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim International GmbH | 2 | $45,733 |
| ANI Pharmaceuticals, Inc. | 8 | $16,438 |
| Bausch & Lomb Americas Inc. | 14 | $4,656 |
| Alimera Sciences, Inc. | 28 | $3,860 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,966 |
| Genentech, Inc. | 4 | $1,905 |
| Regeneron | 1 | $1,375 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $1,042 |
| AbbVie(2 entities) | 31 | $787 |
| Genentech USA, Inc. | 13 | $638 |
| Astellas Pharma US Inc | 18 | $547 |
| Alcon | 10 | $529 |
| Eyepoint US, Inc. | 16 | $485 |
| Apellis Pharmaceuticals, Inc. | 5 | $297 |
| Dutch Ophthalmic, USA | 1 | $151 |
| Hoffmann-la Roche Limited | 1 | $136 |
| Harrow Eye, LLC | 4 | $118 |
| Novartis | 1 | $97 |
| Dompe US, Inc. | 1 | $95 |
| Glaukos Corporation | 1 | $73 |
| Topcon Healthcare Solutions, Inc. | 1 | $43 |
| Mallinckrodt Hospital Products Inc. | 1 | $26 |
| Neurotech Pharmaceuticals, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $21 |
How this compares
$81,043 in reported general payments places this provider in the 55th percentile of 30 retina specialist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Phoenix
- Jordan GraffPhoenix$4.4M
- Henry KwongPhoenix$3.4M
- Alan GordonPhoenix$1.2M
- Stephen de SouzaPhoenix$952K
- Rahul ReddyPhoenix$581K
- Benjamin BakallPhoenix$533K
- Suhail AlamPhoenix$476K
- Jack SipperleyPhoenix$409K
- Joseph BryanPhoenix$199K
- Jaime GaitanPhoenix$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.